The Food and Drugs Board (FDB) has clarified that the order it issued for the recall of Cipro-Dor and Clawu-Dor tablets was related to specific batch numbers and not the drugs in their entirety.
The batch numbers of the drugs manufactured by some Chinese companies, Shijazhuang Pharmaceutical Group, Ouyi Pharma Company Limited and Shandong Reyoung Pharmaceuticals Company Limited are 08C0701 for Cipro-Dor and 071201 and 071202 for Clavu-Dor.
Officials of the FDB clarified the anomaly with the Daily Graphic in Accra yesterday, reiterating that the drugs were related to specific batch numbers and not the entire product. Meanwhile, distributors of the drugs have asked members of the public who have acquired any of the products with such numbers to return them for either a refund or a replacement.
They stated that the potency of the drugs reduced because of defective storage and it was necessary for them to be recalled. The distributors said manufacturers of health products always conducted checks on the market to recall products that had been badly stored for which reason their potency had been affected.
�This we do to ensure that all the drugs we put on the market are potent enough to serve the purpose for which they were produced,� they said.
The distributors also mentioned that the batch numbers affected were being recalled and replaced with new ones and again called on those who had bought any of the drugs to check the package for the batch number and call for a change or refund from where they acquired it for immediate replacement.
They described the drugs as efficacious to deal with the ailments they were intended to deal with and added that there was no cause for alarm.
They gave the assurance that given the international reputation of the manufacturers and the image of the distributors, they would always ensure that what they put on the market was always wholesome, potent and efficacious to serve its purpose.
<<Print>>